Source: Medicines & Healthcare Products Regulatory Agency (GB) Revision Year: 2021 Publisher: Dexcel-Pharma Ltd., 7 Sopwith Way, Drayton Fields, Daventry, Northamptonshire NN11 8PB, UK
Dicloflex 75 mg SR.
Pharmaceutical Form |
---|
Prolonged-release tablet. Pink, round, biconvex tablet, marked “DICL 75” on one side. |
Diclofenac sodium 75 mg.
Excipients(s) with known effect:
Each tablet contains approximately 86 mg Sucrose.
For the full list of excipients, see section 6.1.
Active Ingredient | Description | |
---|---|---|
Diclofenac |
Diclofenac is a non-steroidal anti-inflammatory drug. The mechanism of action of diclofenac in AK may be related to the inhibition of the cycloxygenase pathway leading to reduced prostaglandin E2 (PGE2) synthesis. In addition, immunohistochemistry (IHC) from skin biopsies ac revealed that the clinical effects of diclofenac in AK are primarily due to anti-inflammatory, anti-angiogenic and possibly anti-proliferative effects and apoptosis-inducing mechanisms. |
List of Excipients |
---|
Granulating fluid: Cetostearyl Alcohol Core: Colloidal Silicon Dioxide Subcoat: Copovidone Pigmented film coat: Hydroxypropylmethylcellulose Polish: Carnauba Wax |
The tablets are presented in aluminium/PVC or PVDC-coated-PVC blisters, strips of which are contained within a printed cardboard carton. Cartons of 28 and 56 tablets.
Not all pack sizes may be marketed.
Dexcel-Pharma Ltd., 7 Sopwith Way, Drayton Fields, Daventry, Northamptonshire NN11 8PB, UK
PL 14017/0009
30 January 1997 / 18 February 2003
Drug | Countries | |
---|---|---|
DICLOFLEX | Estonia, Lithuania, United Kingdom |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.